A pharmaceutical preparation comprising a stable, surface-active emulsion or dispersion of a pharmaceutical agent incorporated into an emulsion (i) having a hydrophobic discontinuous phase of a long chain carboxylic acid or ester or alcohol thereof dispersed in an aqueous phase or (ii) having a hydrophilic discontinuous phase dispersed in a hydrophobic phase of a long chain carboxylic acid or alcohol thereof. The emulsion with pharmaceutical agent is incorporated into a pharmaceutical carrier su...

A method of treating human skin to enhance the ability of skin in the absorption and retention of moisture in order to retard skin moisture loss. There is applied to skin an organosilicon compound exhibiting humectant-like characteristics which is an anionic siliconate. An alternate method treats human skin to reduce the transepidermal water loss of skin in order to increase moisturization and to enhance skin softness. There is applied to skin an occlusive film forming organisilicon compound whi...

Novel methods and compositions for the suppression of the desire for food consumption in warm-blooded animals consisting essentially of the administration of 2-phenyl-1,3-propanediol dicarbamate are disclosed.

A therapeutic composition for treating the manifestations of overindulgence in alcohol includes effective amounts of acetaminophen, one or more antacids agents and caffeine, all provided in finely powdered form suspended in a medium including glycerin, xanthan gum and purified water, along with a dissolved simple sugar, such that the composition is basic and has a pH less than 9. The use of a flavorant, a colorant, a stomachic and preservatives in the composition is disclosed. A method of oral a...

A method of treating human skin to enhance the ability of skin in the absorption and retention of moisture in order to retard skin moisture loss. There is applied to skin an organosilicon compound exhibiting humectant-like characteristics which is a carboxylic acid salt functional polysiloxane. An alternate method treats human skin to reduce the transepidermal water loss of skin in order to enhance skin softness. There is applied to skin an occlusive film forming organosilicon compound which is ...

The galenic composition of this invention has been found to possess valuable pharmacological properties in the prevention of the aftereffects related to ingesting excessive amounts of ethanol. The inventive composition decreases blood alcohol concentration and reduces the increased content of neutral fat in the blood due to alcohol intake. The composition comprises an amount of fructose and an aqueous extract of pueraria flower, phaseoli radiati semen and pinelliae tuber sufficient to increase, ...

New uses of certain substituted pyrido[1,2-a]pyrimidin-4-one anti-allergy drugs are made possible by the provision of clear, stable aqueous solutions of same. The aqueous solutions contain novel combinations of drugs and stabilizers.

Pharmaceutical compositions for the improvement of dysuria comprising a pharmaceutical carrier and a therapeutically effective amount of a xanthine derivative represented by the general formula I ##STR1## wherein R.sub.1 denotes a group of the formula R.sub.4 -CO- or R.sub.5 R.sub.6 (OH)C- or a carboxyl group, wherein R.sub.4 and R.sub.5 independently denote an alkyl group having 1-3 carbon atoms, and R.sub.6 denotes a hydrogen atom or an alkyl group having 1-3 carbon atoms, R.sub.2 denotes a hy...

The rate and character of mammalian hair growth is altered by the topical application to the skin of a composition containing an organic inhibitor of the enzyme L-asparagine synthetase.

Methods of treating Irritable Bowel Syndrome (IBS) using a series of isoxazole derivatives that have both 5-HT1A agonist and M1 muscarinic activities, and formulations adapted for the treatment of IBS comprising those derivatives.